ATP-binding cassette transporters in liver

BioFactors

Volumn 40, Issue 2, 2014, Pages 188-198

  Wlcek, Katrin ^a   Stieger, Bruno ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cancer; Expression; Human ABC transporters; Liver; Localization; Ontogenesis

Indexed keywords

ABC TRANSPORTER;

ANIMAL; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; LIVER; LIVER NEOPLASMS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; LIVER; LIVER NEOPLASMS; PROTEIN TRANSPORT;

EID: 84899096795     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1136     Document Type: Review

References (91)

1. Dean, M., Rzhetsky, A., and Allikmets, R. (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156-1166.
2. Ishibashi, H., Nakamura, M., Komori, A., Migita, K., and Shimoda, S. (2009) Liver architecture, cell function, and disease. Semin Immunopathol. 31, 399-409.
3. Suriawinata, A. A. and Thung, S. N. (2002) Malignant liver tumors. Clin. Liver Dis. 6, 527-554, ix.
4. El-Serag, H. B. (2011) Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127.
5. Zarubica, A., Trompier, D., and Chimini, G. (2007) ABCA1, from pathology to membrane function. Pflugers Arch. 453, 569-579.
6. Borel, F., Han, R., Visser, A., Petry, H., van Deventer, S. J., et al. (2012) Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 55, 821-832.
7. Langmann, T., Klucken, J., Reil, M., Liebisch, G., Luciani, M. F., et al. (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257, 29-33.
8. Neufeld, E. B., Demosky, S. J., Jr., Stonik, J. A., Combs, C., Remaley, A. T., et al. (2002) The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem. Biophys. Res. Commun. 297, 974-979.
9. Hoekstra, M., Kruijt, J. K., Van Eck, M., and Van Berkel, T. J. (2003) Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 278, 25448-25453.
10. Hoekstra, M., Out, R., Kruijt, J. K., Van Eck, M., and Van Berkel, T. J. (2005) Diet induced regulation of genes involved in cholesterol metabolism in rat liver parenchymal and Kupffer cells. J. Hepatol. 42, 400-407.
11. van Straten, E. M., Huijkman, N. C., Baller, J. F., Kuipers, F., and Plosch, T. (2008) Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism. Am. J. Physiol. Endocrinol. Metab. 295, E1341-1348.
12. Zhou, S. F. (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 38, 802-832.
13. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., et al. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U S A. 84, 7735-7738.
14. Westerlund, M., Belin, A. C., Olson, L., and Galter, D. (2008) Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients. Cell Tissue Res. 334, 179-185.
15. Hannivoort, R. A., Dunning, S., Vander Borght, S., Schroyen, B., Woudenberg, J., et al. (2008) Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology. 48, 624-634.
16. Konieczna, A., Erdosova, B., Lichnovska, R., Jandl, M., Cizkova, K., et al. (2011) Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos. J. Mol. Histol. 42, 567-574.
17. Cizkova, D., Morky, J., Micuda, S., Osterreicher, J., and Martinkova, J. (2005) Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. Physiol. Res. 54, 419-428.
18. van Kalken, C. K., Giaccone, G., van der Valk, P., Kuiper, C. M., Hadisaputro, M. M., et al. (1992) Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am. J. Pathol. 141, 1063-1072.
19. Effendi, K., Mori, T., Komuta, M., Masugi, Y., Du, W., et al. (2010) Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression. Cancer Sci. 101, 666-672.
20. Vander Borght, S., Komuta, M., Libbrecht, L., Katoonizadeh, A., Aerts, R., et al. (2008) Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int. 28, 1370-1380.
21. Soini, Y., Virkajarvi, N., Raunio, H., and Paakko, P. (1996) Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis. J. Clin. Pathol. 49, 470-473.
22. Chou, Y. Y., Cheng, A. L., and Hsu, H. C. (1997) Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation. J. Gastroenterol. Hepatol. 12, 569-575.
23. Ng, I. O., Liu, C. L., Fan, S. T., and Ng, M. (2000) Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am. J. Clin. Pathol. 113, 355-363.
24. Sun, Z., Zhao, Z., Li, G., Dong, S., Huang, Z., et al. (2010) Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies. Tumori 96, 90-96.
25. Lin, C. C., Hwang, J. M., Tsai, M. T., Su, W. W., Chen, L. M., et al. (2010) Protein kinase C alpha location and the expression of phospho-MEK and MDR1 in hepatitis virus-related hepatocellular carcinoma biopsies. Chin. J. Physiol. 53, 112-118.
26. Grude, P., Conti, F., Mennecier, D., Louvel, A., Houssin, D., et al. (2002) MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis. Cancer Lett. 186, 107-113.
27. Richart, J., Brunt, E. M., and Di Bisceglie, A. M. (2002) Expression of P-glycoprotein and C-MOAT in human hepatocellular carcinoma: detection by immunostaining. Dig. Dis. Sci. 47, 2454-2458.
28. Zollner, G., Wagner, M., Fickert, P., Silbert, D., Fuchsbichler, A., et al. (2005) Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int. 25, 367-379.
29. Komuta, M., Spee, B., Vander Borght, S., De Vos, R., Verslype, C., et al. (2008) Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 47, 1544-1556.
30. Larbcharoensub, N., Sornmayura, P., Sirachainan, E., Wilasrusmee, C., Wanmoung, H., et al. (2011) Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma. Histopathology 59, 235-246.
31. Vander Borght, S., van Pelt, J., van Malenstein, H., Cassiman, D., Renard, M., et al. (2008) Up-regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: a study in patients and in vitro. Hepatol. Res. 38, 1112-1121.
32. Oue, T., Yoneda, A., Uehara, S., Yamanaka, H., and Fukuzawa, M. (2009) Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies. J. Pediatr. Surg. 44, 377-380.
33. Oude Elferink, R. P. and Paulusma, C. C. (2007) Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 453, 601-610.
34. Scheffer, G. L., Kool, M., Heijn, M., de Haas, M., Pijnenborg, A. C., et al. (2000) Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res. 60, 5269-5277.
35. Chen, H. L., Liu, Y. J., Feng, C. H., Wu, C. Y., Shyu, M. K., et al. (2005) Developmental expression of canalicular transporter genes in human liver. J. Hepatol. 43, 472-477.
36. Cui, Y. J., Cheng, X., Weaver, Y. M., and Klaassen, C. D. (2009) Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab. Dispos. 37, 203-210.
37. Macias, R. I., Jimenez, S., Serrano, M. A., Monte, M. J., and Marin, J. J. (2006) Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sci. 79, 1014-1019.
38. Frank, N. Y., Pendse, S. S., Lapchak, P. H., Margaryan, A., Shlain, D., et al. (2003) Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278, 47156-47165.
39. Cheung, S. T., Cheung, P. F., Cheng, C. K., Wong, N. C., and Fan, S. T. (2011) Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 140, 344-355.
40. Krishnamurthy, P. C., Du, G., Fukuda, Y., Sun, D., Sampath, J., et al. (2006) Identification of a mammalian mitochondrial porphyrin transporter. Nature 443, 586-589.
41. Polireddy, K., Chavan, H., Abdulkarim, B. A., and Krishnamurthy, P. (2011) Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma. Mol. Oncol. 5, 410-425.
42. Emadi-Konjin, H. P., Zhang, H., Anandan, V., Sun, D., Schuetz, J., et al. (2002) Isolation of a genomic clone containing the promoter region of the human ATP binding cassette (ABC) transporter, ABCB6. Biochim. Biophys. Acta. 1574, 117-130.
43. Stieger, B., Meier, Y., and Meier, P. J. (2007) The bile salt export pump. Pflugers Arch. 453, 611-620.
44. Jansen, P. L., Strautnieks, S. S., Jacquemin, E., Hadchouel, M., Sokal, E. M., et al. (1999) Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117, 1370-1379.
45. Sharma, S., Ellis, E. C., Gramignoli, R., Dorko, K., Tahan, V., et al. (2013) Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes. Drug Metab. Dispos. 41, 296-304.
46. Gao, B., St Pierre, M. V., Stieger, B., and Meier, P. J. (2004) Differential expression of bile salt and organic anion transporters in developing rat liver. J. Hepatol. 41, 201-208.
47. St-Pierre, M. V., Stallmach, T., Freimoser Grundschober, A., Dufour, J. F., Serrano, M. A., et al. (2004) Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1505-1516.
48. Zinchuk, V. S., Okada, T., Akimaru, K., and Seguchi, H. (2002) Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G540-548.
49. Tomer, G., Ananthanarayanan, M., Weymann, A., Balasubramanian, N., and Suchy, F. J. (2003) Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr. Res. 53, 288-294.
50. Chen, Y., Song, X., Valanejad, L., Vasilenko, A., More, V., et al. (2013) Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology 57, 1530-1541.
51. He, S. M., Li, R., Kanwar, J. R., and Zhou, S. F. (2011) Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr. Med. Chem. 18, 439-481.
52. Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., et al. (1996) Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148, 1237-1247.
53. Nies, A. T., Konig, J., Pfannschmidt, M., Klar, E., Hofmann, W. J., et al. (2001) Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int. J. Cancer. 94, 492-499.
54. Vander Borght, S., Libbrecht, L., Blokzijl, H., Faber, K. N., Moshage, H., et al. (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J. Pathol. 207, 471-482.
55. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., et al. (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57, 3537-3547.
56. Ros, J. E., Libbrecht, L., Geuken, M., Jansen, P. L., and Roskams, T. A. (2003) High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J. Pathol. 200, 553-560.
57. de Zwart, L., Scholten, M., Monbaliu, J. G., Annaert, P. P., Van Houdt, J. M., et al. (2008) The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod. Toxicol. 26, 220-230.
58. Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., and Klaassen, C. D. (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab. Dispos. 33, 947-955.
59. Nies, A. T. and Keppler, D. (2007) The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 453, 643-659.
60. Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., et al. (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25, 1539-1542.
61. Sandusky, G. E., Mintze, K. S., Pratt, S. E., and Dantzig, A. H. (2002) Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays. Histopathology 41, 65-74.
62. Johnson, D. R., Guo, G. L., and Klaassen, C. D. (2002) Expression of rat Multidrug Resistance Protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny. Toxicology 178, 209-219.
63. Rosati, A., Maniori, S., Decorti, G., Candussio, L., Giraldi, T., et al. (2003) Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev. Growth Differ. 45, 377-387.
64. Korita, P. V., Wakai, T., Shirai, Y., Matsuda, Y., Sakata, J., et al. (2010) Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol. Rep. 23, 965-972.
65. Tsuboyama, T., Onishi, H., Kim, T., Akita, H., Hori, M., et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255, 824-833.
66. Borst, P., de Wolf, C., and van de Wetering, K. (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 453, 661-673.
67. Konig, J., Rost, D., Cui, Y., and Keppler, D. (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29, 1156-1163.
68. Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., et al. (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. U S A. 96, 6914-6919.
69. Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M., Pijnenborg, A. C., et al. (2002) Tissue distribution and induction of human multidrug resistant protein 3. Lab. Invest. 82, 193-201.
70. Gradhand, U., Lang, T., Schaeffeler, E., Glaeser, H., Tegude, H., et al. (2008) Variability in human hepatic MRP4 expression: influence of cholestasis and genotype. Pharmacogenomics J. 8, 42-52.
71. Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., and Keppler, D. (2003) Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38, 374-384.
72. Sekine, S., Ogawa, R., Ojima, H., and Kanai, Y. (2011) Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Sci. 102, 1742-1747.
73. Keppler, D. (2011) Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb. Exp. Pharmacol. 299-323.
74. Scheffer, G. L., Hu, X., Pijnenborg, A. C., Wijnholds, J., Bergen, A. A., et al. (2002) MRP6 (ABCC6) detection in normal human tissues and tumors. Lab. Invest. 82, 515-518.
75. Beck, K., Dang, K., and Boyd, C. D. (2005) The tissue distribution of murine Abcc6 (Mrp6) during embryogenesis indicates that the presence of Abcc6 in elastic tissues is not required for elastic fiber assembly. J. Mol. Histol. 36, 167-170.
76. Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., et al. (1991) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253, 202-205.
77. Bear, C. E., Li, C. H., Kartner, N., Bridges, R. J., Jensen, T. J., et al. (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68, 809-818.
78. Cohn, J. A., Strong, T. V., Picciotto, M. R., Nairn, A. C., Collins, F. S., et al. (1993) Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105, 1857-1864.
79. Kinnman, N., Lindblad, A., Housset, C., Buentke, E., Scheynius, A., et al. (2000) Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32, 334-340.
80. Tizzano, E. F., Chitayat, D., and Buchwald, M. (1993) Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum. Mol. Genet. 2, 219-224.
81. Wiesinger, C., Kunze, M., Regelsberger, G., Forss-Petter, S., and Berger, J. (2013) Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J. Biol. Chem. 288, 19269-19279.
82. Hoftberger, R., Kunze, M., Weinhofer, I., Aboul-Enein, F., Voigtlander, T., et al. (2007) Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol. Dis. 28, 165-174.
83. Meyer zu Schwabedissen, H. E. and Kroemer, H. K. (2011) In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2). Handb. Exp. Pharmacol. 325-371.
84. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., et al. (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61, 3458-3464.
85. Vander Borght, S., Libbrecht, L., Katoonizadeh, A., van Pelt, J., Cassiman, D., et al. (2006) Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences. J. Histochem. Cytochem. 54, 1051-1059.
86. Zen, Y., Fujii, T., Yoshikawa, S., Takamura, H., Tani, T., et al. (2007) Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am. J. Pathol. 170, 1750-1762.
87. Merino, G., van Herwaarden, A. E., Wagenaar, E., Jonker, J. W., and Schinkel, A. H. (2005) Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol. Pharmacol. 67, 1765-1771.
88. Kusuhara, H. and Sugiyama, Y. (2007) ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch. 453, 735-744.
89. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., et al. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-1775.
90. Klett, E. L., Lee, M. H., Adams, D. B., Chavin, K. D., and Patel, S. B. (2004) Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine. BMC Gastroenterol. 4, 21.
91. Hines, R. N. (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol. Ther. 118, 250-267.